Literature DB >> 11256612

Catalysis of serine oligopeptidases is controlled by a gating filter mechanism.

V Fülöp1, Z Szeltner, L Polgár.   

Abstract

Proteases have a variety of strategies for selecting substrates in order to prevent uncontrolled protein degradation. A recent crystal structure determination of prolyl oligopeptidase has suggested a way for substrate selection involving an unclosed seven-bladed beta-propeller domain. We have engineered a disulfide bond between the first and seventh blades of the propeller, which resulted in the loss of enzymatic activity. These results provided direct evidence for a novel strategy of regulation in which oscillating propeller blades act as a gating filter during catalysis, letting small peptide substrates into the active site while excluding large proteins to prevent accidental proteolysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11256612      PMCID: PMC1083722          DOI: 10.1093/embo-reports/kvd048

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  26 in total

Review 1.  Beta propellers: structural rigidity and functional diversity.

Authors:  V Fülöp; D T Jones
Journal:  Curr Opin Struct Biol       Date:  1999-12       Impact factor: 6.809

2.  New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.

Authors:  B Portevin; A Benoist; G Rémond; Y Hervé; M Vincent; J Lepagnol; G De Nanteuil
Journal:  J Med Chem       Date:  1996-06-07       Impact factor: 7.446

3.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities.

Authors:  R M Esnouf
Journal:  J Mol Graph Model       Date:  1997-04       Impact factor: 2.518

4.  The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain.

Authors:  Z Szeltner; V Renner; L Polgár
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains.

Authors:  M Paoli; B F Anderson; H M Baker; W T Morgan; A Smith; E N Baker
Journal:  Nat Struct Biol       Date:  1999-10

Review 6.  Proline specific peptidases.

Authors:  D F Cunningham; B O'Connor
Journal:  Biochim Biophys Acta       Date:  1997-12-05

7.  pH-dependent mechanism in the catalysis of prolyl endopeptidase from pig muscle.

Authors:  L Polgar
Journal:  Eur J Biochem       Date:  1991-04-23

8.  Prolyl endopeptidase from Flavobacterium meningosepticum: cloning and sequencing of the enzyme gene.

Authors:  T Yoshimoto; A Kanatani; T Shimoda; T Inaoka; T Kokubo; D Tsuru
Journal:  J Biochem       Date:  1991-12       Impact factor: 3.387

9.  Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats.

Authors:  N Miura; S Shibata; S Watanabe
Journal:  Neurosci Lett       Date:  1995-08-18       Impact factor: 3.046

Review 10.  Prolyl endopeptidase.

Authors:  S Wilk
Journal:  Life Sci       Date:  1983-11-28       Impact factor: 5.037

View more
  20 in total

Review 1.  Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.

Authors:  C Osorio; N Wen; R Gemini; R Zemetra; D von Wettstein; S Rustgi
Journal:  Funct Integr Genomics       Date:  2012-06-26       Impact factor: 3.410

2.  A typhus group-specific protease defies reductive evolution in rickettsiae.

Authors:  Nicole C Ammerman; Joseph J Gillespie; Andrew F Neuwald; Bruno W Sobral; Abdu F Azad
Journal:  J Bacteriol       Date:  2009-10-09       Impact factor: 3.490

3.  Influence of circular permutations on the structure and stability of a six-fold circular symmetric designer protein.

Authors:  Bram Mylemans; Hiroki Noguchi; Els Deridder; Eveline Lescrinier; Jeremy R H Tame; Arnout R D Voet
Journal:  Protein Sci       Date:  2020-10-16       Impact factor: 6.725

Review 4.  Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

Authors:  Robin S B Williams
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

5.  Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity.

Authors:  Lu Shan; Irimpan I Mathews; Chaitan Khosla
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

6.  Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.

Authors:  Shu Y Qi; Pierre J Riviere; Jerzy Trojnar; Jean-Louis Junien; Karen O Akinsanya
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

7.  Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.

Authors:  Lu Shan; Thomas Marti; Ludvig M Sollid; Gary M Gray; Chaitan Khosla
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

8.  Dipeptidyl aminopeptidase IV from Stenotrophomonas maltophilia exhibits activity against a substrate containing a 4-hydroxyproline residue.

Authors:  Yoshitaka Nakajima; Kiyoshi Ito; Tsubasa Toshima; Takashi Egawa; Heng Zheng; Hiroshi Oyama; Yu-Fan Wu; Eiji Takahashi; Kiyoshi Kyono; Tadashi Yoshimoto
Journal:  J Bacteriol       Date:  2008-09-26       Impact factor: 3.490

9.  Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.

Authors:  Jofre Tenorio-Laranga; Francisco Coret-Ferrer; Buenaventura Casanova-Estruch; María Burgal; J Arturo García-Horsman
Journal:  J Neuroinflammation       Date:  2010-04-06       Impact factor: 8.322

10.  Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation.

Authors:  Kathleen Aertgeerts; Sheng Ye; Mike G Tennant; Michelle L Kraus; Joe Rogers; Bi-Ching Sang; Robert J Skene; David R Webb; G Sridhar Prasad
Journal:  Protein Sci       Date:  2004-01-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.